Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Neurology
•
Vascular Neurology
•
Hospital Medicine
How do you manage acute ischemic stroke patients secondary to HUS/TTP?
Is there a certain platelet value cutoff that you would consider adding antithrombotics?
Related Questions
How to approach reversal of TNK in hemorrhagic conversion of ischemic stroke?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
How long would you continue chronic transfusion therapy for adult sickle cell patients who have had a stroke?
Do you use dual anti-platelet therapy inpatients with low NIHSS who have had bilateral brainstem strokes?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
What is your approach to managing patients who initially present with symptomatic intracranial large vessel occlusion but subsequently experience resolution of symptoms or become non-disabling before any intervention?
How would you approach the upfront management of a patient with acute unilateral vision loss with strong clinical risk factors for both cardioembolic stroke and GCA if an expedited MRI is not possible due to the presence of an AICD?
What is your approach to management and surveillance in low grade traumatic blunt ICA injury?
When do you consider lumbar spinal fluid drainage after acute spinal cord injury?
Would you consider giving thrombolytic therapy for patients with acute vision loss concerning for CRAO based on history and within the window before any ophthalmological assessment and confirmation?